This is the authors' abstract. We don't add key points for this paper.
Craniofacial surgery is an important conduit for tissue-engineering applications. As interdisciplinary collaborations improve, we can expect to see remarkable progress in de novo tissue synthesis, replacement, and repair. Ultimately, we may one day find that gene-modified cell-based tissue-engineering strategies will succeed today's reconstructive strategies. In this review, we highlight the major gene- and cell-based preclinical tools and techniques that are currently being developed to solve common craniofacial problems.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Warren et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: